MedCity News December 21, 2021
The Covid-19 pandemic has brought a laser focus to the critical and immediate need for next-generation sequencing tools that can generate invaluable data for not only identifying emerging variants but for understanding the functional and epidemiological consequences of variant-specific mutations.
The Human Genome Project began over thirty years ago, taking more than thirteen years and 2.7 billion dollars to complete. Much of that hefty price tag came in the form of a genomics-inspired revolution in research and medicine. Today, sequencing technology itself has also been revolutionized, allowing for the simultaneous sequencing of an entire human genome in one day.
NGS technologies have been around since the early 2000s and have reached the point where they can cost-effectively and rapidly generate...
Today's Sponsors
Today's Sponsor